Omnipaque recalls
The FDA has published 2 recalls involving Omnipaque since 2013. The latest was reported on 12 Nov 2014. Most were for sterility. Oregon Compounding Centers has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 12 Nov 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why omnipaque is recalled
Companies
By year
All omnipaque recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Omnipaque, 300mgI/mL, injectable glass vial, RX recalled | Oregon Compounding Centers | Sterility | OR, WA |
| Drug | CLASS II | Omnipaque 240mg/mL PF, 300mg/mL PF, in, and, vials recalled | New England Compounding Center | Sterility | Nationwide |
Should you stop taking Omnipaque?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.